Tri-(2-chloroisopropyl)phosphate


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
10148 EBI3 Increases expression PMID:29143341
1374 CPT1A Decreases expression PMID:30966736
1376 CPT2 Increases expression PMID:30966736
1583 CYP11A1 Increases expression PMID:22446829
1586 CYP17A1 Decreases expression PMID:22446829; PMID:36115506
1588 CYP19A1 Increases expression PMID:22446829
3263 HPX Decreases expression PMID:29143341
3284 HSD3B2 Increases expression PMID:22446829
5027 P2RX7 Increases expression PMID:29143341
5465 PPARA Decreases expression PMID:30966736
5468 PPARG Decreases expression PMID:30966736
6720 SREBF1 Increases expression PMID:30966736
6721 SREBF2 Increases expression PMID:30966736
6770 STAR Decreases expression PMID:36115506
6783 SULT1E1 Decreases expression PMID:22446829
6822 SULT2A1 Decreases expression PMID:22446829
7157 TP53 Increases expression PMID:25510514
728 C5AR1 Increases expression PMID:29143341
730 C7 Decreases expression PMID:29143341
8694 DGAT1 Increases expression PMID:30966736
8856 NR1I2 Increases activity PMID:24051214; PMID:26778350
949 SCARB1 Decreases expression PMID:36115506

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.